Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masatoshi Kikuchi is active.

Publication


Featured researches published by Masatoshi Kikuchi.


Arthritis & Rheumatism | 2001

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient.

Satoshi Ito; Kiyoshi Nakazono; Akira Murasawa; Yusaku Mita; Kojiro Hata; Noriko Saito; Masatoshi Kikuchi; Kazukiyo Yoshida; Masaaki Nakano; Fumitake Gejyo

A 75-year-old female rheumatoid arthritis patient who was positive for hepatitis B surface antigen and for antibodies to hepatitis Be antigen showed liver dysfunction, and therefore methotrexate (MTX) therapy was discontinued. Her drug lymphocyte stimulation test indicated positivity for MTX. Her liver dysfunction improved briefly, but she developed fulminant hepatitis with elevated levels of hepatitis B virus (HBV)/DNA polymerase and subsequently died. HBV/DNA analysis performed with polymerase chain reaction-mutation site-specific assay revealed that the fulminant hepatitis was caused by a precore mutant virus. Sudden reactivation of the immune system by discontinuation of MTX may have led to the attack on infected cells. Even when hepatitis Be antibodies are present, MTX should not be used in patients who have chronic infection with HBV.


Japanese Journal of Rheumatology | 1998

Determination of procollagen type I carboxyterminal propeptide in Japanese patients with systemic sclerosis

Masaaki Nakano; Hisashi Hasegawa; Takeshi Watanabe; Takeshi Kuroda; Masatoshi Kikuchi; Eiichi Suzuki; Masaaki Arakawa

Our objective was to clarify the relationship between the serum levels of procollagen type I carboxyterminal propeptide (PICP) and the extent of skin sclerosis or pulmonary fibrosis in patients with systemic sclerosis (SSc). Thirty-eight SSc patients and 36 control subjects were examined for serum PICP levels using enzyme-linked immunosorbent assay. SSc patients were divided into two subgroups according to the grade of skin sclerosis. Mean PICP level in the SSc patients was significantly higher than that in the normal controls. In 53% of the SSc patients, the serum PICP levels were elevated more than 3 SD above the mean control value. The SSc patients with elevated serum PICP levels showed a high incidence of pulmonary fibrosis of diffuse skin sclerosis compared to those with normal PICP levels. Moreover, in 17 patients with pulmonary fibrosis there was an increase in the percentage of patients with elevated PICP levels in the group with diffuse SSc compared to that in the limited SSc group. Furthermore, there was a significant negative correlation between PICP levels and partial pressure of arterial oxygen levels (r=−0.744). We conclude that serum PICP levels may be a useful parameter for the evaluation of skin sclerosis and pulmonary fibrosis of SSc patients.


Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine | 1988

A case of strongyloidiasis associated with parasitic rheumatism.

Hidemi Ohi; Takehiro Sato; Tetsuo Ozawa; Masatoshi Kikuchi; Eiichi Suzuki; Masaaki Nakano; Masaaki Arakawa

Parasitic rheumatismと考えられた糞線虫症の1例を経験したので報告する.症例は20才,男性,ベトナム人.昭和58年,某院で慢性関節リウマチを疑われ,大量のステロイド薬を使用にて軽快.しかし著しい下痢が出現したため,当科に入院した.リウマチ反応は陰性, HLA-B27陽性であった.糞線虫が証明されたため駆虫療法を開始し,腹部症状は軽快したが,関節症状は増悪した.滑膜生検で,非特異的慢性炎症所見が認められた.なお,糞線虫に対する抗体は陰性であった.本例はDouryらのparasitic rheumatismの診断基準に合致した.発症機序に関しては,免疫複合体が重要と考えられた.一方, HLA-B27が陽性であり,発症ならびに進展に遺伝的な因子の関与も考えられた.


Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine | 1989

A case of mixed connective tissue disease accompanied with idiopathic portal hypertension and pulmonary hypertension

Tetsuo Ozawa; Nakagawa O; Hasegawa S; Tomoko Honma; Masatoshi Kikuchi; Takehiro Sato; Masaaki Nakano; Masaaki Arakawa


Japanese Journal of Clinical Immunology | 1992

Antiphospholipid antibodies in patients with collagen diseases

Masatoshi Kikuchi


Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine | 1989

[A case of MCTD with pulmonary hypertension showing elevated serum angiotensin I-converting enzyme activity].

Tetsuo Ozawa; Yutaka Ninomiya; Tadahisa Ogiwara; Tomoko Honma; Masatoshi Kikuchi; Yoshiyuki Takano; Takehiro Sato; Masaaki Nakano; Masaaki Arakawa


Japanese Journal of Rheumatology | 1994

Incidence of infection in patients with systemic lupus erythematosus

Takehiro Sato; Satoshi Ito; T. Honma; T. Ozawa; Masatoshi Kikuchi; Eiji Suzuki; Masaaki Nakano; Masaaki Arakawa


新潟医学会雑誌 | 1992

4) 慢性関節リウマチの関節外症状と免疫異常(シンポジウム 慢性関節リウマチ : 最近の話題, 第464回新潟医学会)

正明 中野; 聡 伊藤; 智子 本間; 哲夫 小澤; 正俊 菊池; 健比呂 佐藤; 正昭 荒川; Masaaki Nakano; Satoshi Ito; Tomoko Honma; Tetuo Ozawa; Masatoshi Kikuchi; Takehiro Sato; Masaaki Arakawa


Japanese Journal of Clinical Immunology | 1992

The value of circulating immune complexes and plasma complement derived products in monitoring disease activity in patients with SLE

Tetsuo Ozawa; Tomoko Honma; Masatoshi Kikuchi; Takehiro Sato; Masaaki Nakano; Masaaki Arakawa


Japanese Journal of Clinical Immunology | 1991

Low-dose methotrexate therapy for leukocytoclastic vasculitis associated with rheumatoid arthritis

Masatoshi Kikuchi; Chikako Takahashi; Kiyoshi Nakazono; Akira Murasawa; Tetsuo Ozawa; Takehiro Satoh; Masaaki Nakano; Masaaki Arakawa

Collaboration


Dive into the Masatoshi Kikuchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge